
|Articles|May 8, 2018
New Registry for Migraine Patients
Advertisement
The American Migraine Foundation (AMF) has developed a U.S. patient registry and biorepository for migraine. In collaboration with ZS, the AMF also has built a technology solution that sets out to collect a wide range of clinical and biological information from patients with migraine and other headache disorders, and to study that information over the course of an extended period of time.
AMF's American Registry for Migraine Research (ARMR) incorporates biological samples, leverages machine learning, and uses patient-reported outcomes, electronic health record and physician-captured data, and a mobile headache diary application to track the progress of patients over time.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
U.S. Supreme Court Unanimously Votes in Favor of Hikma in Case Against Amarin: Report
2
Chai Discovery Enters License Agreement with Pfizer to Accelerate Drug Discovery with AI
3
Alnylam Enters $2 Billion Strategic AI Collaboration with Inceptive
4
New FDA Draft Guidance Targets Gene Therapy Submission Burden by Allowing Use of Existing CMC and Scientific Knowledge
5




